Introduction
Hydronephrosisresults fromthe obstruction and stasis of urinary flow, which is nowa relatively common disorder encountered by physicians in daily practice because of the advances in ultrasonography. However, "giant hydronephrosis", a kidney containing more than 1,000 ml of fluid in its collecting system, is uncommon.The serum level of the tumor marker CA19-9 is known to be elevated in patients with gastrointestinal tumors, especially, pancreatic carcinoma. In the field of urology, increased serum CA 19-9 levels have been reported in patients with pyeloureteral tumors; however, to our knowledge, only 6 cases of the benign disorder, hydronephrosis, including the present case, were reported to have significant elevations of the marker. Of these, in 5 cases (including the present case) the localization of CA1 9-9 was proved immunohistochemically through staining of CA 19-9 (Table 1) (1-5).
For editorial comment, see also p 840.
Case Report
A 42-year-old womanexperienced a sensation of left flank distention beginning around July 1997 and came to our hospital for consultation on August 7, 1997 . Since an elastic hard mass and slight tenderness were noted in the left flank, she was admitted for detailed examination. Past history was unremarkable. Onadmission, the results of blood count, blood biochemical studies and urinalysis were within normal limits. The tumor marker CA19-9 level was markedly elevated (2,500 U/ ml) ( Table 2 ). Plain abdominal radiography showed a radiopaque shadow (10x18 mm) located in the L 3-4 intervertebral area, which appeared to be a calcified stone. Computed tomography (CT) scan of the abdomen revealed a huge cystic lobulated mass in the left kidney and occupying the left intraperitoneal and pelvic cavities. The distention of the left kidney resulted in the thinning of the parenchyma. The cystic mass extended beyond the median line, with a shadow indicative of a calcific stone visualized in the same site as depicted on the plain abdominal film (Fig. 1) . The calcific body was seen on the right side of the vertebral bodies because of the advanced stage of hydronephrosis. No abnormalities were found in the other organs examined, including the liver, gall bladder and pancreas. Excretory urography revealed no significant excretion from the left kidney, indicating the lack of renal function. Urine cytology provided no signs of abnormality. Based on the findings from diagnostic imaging, cytology and other examinations, the patient was diagnosed as having giant left hydronephrosis, attributable to a left ureteral stone, with lack of left renal function. In September 1997, left nephrectomy was performed in the light of the risk that the thinning of the renal parenchyma would cause rupture of the kidney and because of the severe abdominal distention due to the enlarged left kidney. An oblique incision was made in the left pelvic region, reaching the retroperitoneal cavity. A huge hydronephrotic kid- Table 2 . Laboratory Data on Admission ney was exposed. The hydronephrotic sac was drained by suction of its contents through a small incision and it was ablated from adjacent tissues. Then, left nephrectomy was performed. By aspiration, approximately 2,000 ml of fluid was removed. The cross-section of the resected kidney showedmarked pyelocaliectasis, and a pale yellow stone was present in the ureteropelvic junction (UPJ) ( Fig. 2A) . Chronic interstitial inflammation was observed extending into the mucosaof the renal pelvis, parenchyma and ureter. The thin renal parenchyma, showing significant fibrosis, retained only sparse tubules among the replaced fibrous elements and was devoid of normal parenchymal structure (Fig. 2B) . No evidence of malignancy was found. The left kidney appeared to be in the terminal stage of deterioration, having lost its function. No specific abnormalities were noted in the UPJ. Immunohistochemical staining of CA19-9 by the enzyme-labeled antibody technique showed positive reactions at various sites in the epithelium of the UPJ (Fig. 3) . The postoperative course was uneventful. The serum CA19-9 level has been within the normal range since discharge from hospital. 
Discussion
Hydronephrosis is the distention of the pelvis and calyces of the kidney due to the obstruction and stasis of urinary flow caused by a lesion in the upper or lower tract. The disorder is relatively commonly found in everyday practice. However, "giant hydronephrosis", defined by Stirling (6) to designate the presence of 1,000 ml or more fluid in the collecting system, is rare, with only 373 cases reported so far in Japan according to the review by Morimitsu et al (7) . Most cases of giant hydronephrosis result from the development of a lesion in the upper urinary tract, which is thought to be because a lesion of lower tract origin, often bilateral, tends to cause a reduction in renal function in the early stage of the process, producing various subjective/objective manifestations, and is thus frequently detected before the hydronephrotic kidney grows into a giant mass. It has been reported that 47 of the 49 cases could be attributed to upper tract lesions (7). Morimitsu et al (7) reported that an abnormality in the UPJ was the most commoncause of giant hydronephrosis, followed by stones, congenital ureteral narrowing and ureteropelvic tumors in order of decreasing incidence. The present case was a giant hydronephrosis of the left kidney due to a ureteral stone. Once the presence of giant hydronephrosis is known, the important issue in treatment is howto arrive at a preoperative diagnosis of a ureteropelvic tumor associated with the disease. Whenthe patient is aged 50 years or older and presents with hematuria, in particular, the possible coexistence of a malignant tumor should be considered; thus, it is preferable to conduct a detailed exploration of the renal pelvis and calyces by such means as CTscan, ultrasonography, magnetic resonance imaging, etc., and to perform repeated cytologic studies of the urine. In our case, no signs indicative of malignancywere found by repeated urinary cytology, abdominal ultrasonography, or CT scanning. The decision between nephrectomy and kidney-conserving Internal Medicine Vol. 38, No. ll (November 1999) therapy should be a critical issue in the management of giant hydronephrosis. However, in practice, nephrectomy has been performed in the majority of instances. Hoffman (8) stated that nephrectomy is frequently the only therapy for giant hydronephrosis with a capacity of or above 1,000 ml because there is no feasible prospect of improvement in renal function. We also believe that nephrectomy is the treatment of choice in principle if the function of the contralateral kidney is normal. The primary reasons are that the existence of the huge hydronephrotic kidney, even when retaining some function, is likely to cause gastrointestinal disturbances from compression and also wouldbe subject to trauma. In addition, the risk of development of malignant tumor due to chronic stimulation by stones, if present, should be considered (9) . Weperformed nephrectomy in the present case, because no excretion of contrast medium was observed on drip infusion pyelography examination and the renal parenchyma was scarcely visible by CT scanning, strongly indicating the lack of renal function. CA 1 9-9 is a tumor-associated carbohydrate antigen discovered by Koprowski et al (10) using a monoclonal antibody against a human colorectal carcinoma cell line. It has become widely accepted as one of the most useful tumor markers in the diagnosis and management of cancer patients. This antigen, monosialoganglioside, is known to have a carbohydrate structure as a sialyl derivative of lacto-N-fucopentaose II, a hapten of the human Lewis blood group antigen (ll) . It is present in trace amounts in normal humanepithelia (12) . However, with the development of carcinoma, the antigen will be synthesized in large quantities and appear in blood and secretions. CA19-9 is frequently detected in the serum of patients with gastrointestinal carcinoma in general; it is especially elevated in patients with pancreatic and bile duct carcinomas in that order of decreasing frequency of detection ( 13) . Immunohistochemical assay (12) can also frequently detect CA19-9 in the tissue of various adenocarcinomas, mainly gastrointestinal carcinoma. Thus, CA19-9 is a major marker and is elevated in patients with hepatocellular, bile duct, pancreatic and other carcinomas. Although the CA19-9 level is known to rise in patients with benign disorders, there is a report (14) stating that an excessive elevation in serum CA19-9 exceeding 1,000 U/ml can be attributed to a malignant disorder in 99% of cases. In the field of urology, there are also patients with ureteropelvic transitional cell carcinoma whoexhibit elevations in serum CA19-9 and positive immunohistochemical staining of the antigen in tumor cells (15) (16) (17) . CA19-9 has been reported to be present in the tubules and pelvic mucosa of normal kidneys (18) . In addition, cases of the benign disorder, hydronephrosis, presenting with excessive elevations of CA19-9 have been reported (1) (2) (3) (4) (5) . Amongthese hydronephrotic patients, the localization of CA19-9 in the mucosa of the renal pelvis has been proved in 5 cases, including the present case, by use of the immunohistochemical staining technique of the antigen (Table 1 ). All 5 reported cases are Japanese cases. It is of interest that the abnormality in CA19-9 level in such cases has been reported only in Japan despite the fact that serum CA19-9 is a major tumor marker determined frequently in various patients in many countries. This phenomenon, whether derived from a racial difference or another cause, or purely by chance, should be elucidated by studies in a greater number of patients.
The mechanism of abnormal elevations in serum CA19-9 in patients with hydronephrosis can be explained by 1) abnormal synthesis of the antigen in sites other than the kidneys, 2) synthesis in the gastrointestinal organs surrounding the kidney-(s) which is induced by compression from hydronephrosis or 3) excessive synthesis in the mucosaof the renal pelvis resulting from chronic inflammation. In the present case, interpretation 1 is unlikely because of the finding that the serum CA19-9 values decreased to the normal range by resection of the affected kidney and that no malignant tumor was found through the subsequent follow-up period. The second notion is also unlikely from the findings of CT scan and ultrasonographic examinations, which indicate a low possibility of compression of the pancreas, bile duct, gall bladder and other organs by the hydronephrotic kidney. The third is the most probable hypothesis, as CA19-9 has been shown to be localized in the mucosa of the renal pelvis by immunohistochemical staining. Thus, in our case, this also may be considered the most probable cause of the elevated levels of CA19-9. The excessive production of the antigen in the renal pelvic mucosamayhave resulted from long-term, chronic inflammation secondary to hydronephrosis or CA 19-9 may have been synthesized in the renal pelvic membrane and released into the blood circulation by an increase in the internal pressure of the renal pelvis due to hydronephrosis. In any case, urinary tract obstruction that has been present over a period of years appears to be implicated in a significant elevation of serum CA19-9 values. The utility of CA19-9 as a tumor marker for urologic carcinomais now under evaluation. Keeping in mind that CA19-9 levels mayalso increase in patients with benign disorders of the renal tubules and pelvis, further accumulation of clinical data should be conducted. Although no malignancy of the kidneys was found in the 6 patients with hydronephrosis accompanied by elevations in serum CA19-9 (Table 1) , it would be of interest to determine whether malignant lesions develop in such hydronephrotic patients during the follow-up period, and, if so, whether a rise in serum CA19-9accompanies this process. It is also important to know whether hydronephrotic patients with increased serum CA19-9 levels have a higher risk of developing cancer than those without such an elevation. Thus, further studies, including those using immunohistochemical and molecular biological approaches, appear to be needed.
